单位:[1]Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, China[2]Division of Molecular Medicine, Department of Anesthesiology, Division of Cardiology, Department of Medicine, Cardiovascular Research Laboratories, David Geffen School of Medicine at University of California Los Angeles (UCLA), California, 90095
Since the initial marketing in 2005, the use of e-cigarettes has increased exponentially. Nonetheless, accumulating evidence has demonstrated the ineffectiveness of e-cigarettes in leading to smoking cessation, and decreasing the adverse health impacts of cigarette smoking. The number of adolescents adapted to e-cigarettes has been increasing substantially each year, and this adaptation has promoted openness to tobacco smoking. The present review discusses controversies regarding the smoking cessation effects of e-cigarettes, recent governmental policies and regulations of e-cigarette use, toxic components and vaporization products of e-cigarettes, and the novel molecular mechanisms underlying the adverse health impacts of e-cigarettes leading to oxidative stress in target tissues, and consequent development of cardiopulmonary diseases (i.e. COPD), neurodegenerative disorders (Le. Alzheimer's' disease), and cancer. Health warning signs on the packaging and professional consultation to avoid adaptation in risk groups might be helpful solutions to control negative impacts of e-cigarettes. It is also recommended to further expand basic and clinical investigations to reveal more detailed oxidative stress mechanisms of e-cigarette induced damages, which would ultimately result in more effective protective strategies.
基金:
National Key Research and Development Program of China [2016YFC1303900, 2016YFC0901102]; National Institute of Health National Heart, Lung and Blood Institute (NHLBI)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL077440, HL088975, HL108701, HL119968]; American Heart Association Established Investigator Award (EIA) [12EIA8990025]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL077440, R01HL108701, R01HL119968, R01HL088975] Funding Source: NIH RePORTER
第一作者单位:[1]Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, China[2]Division of Molecular Medicine, Department of Anesthesiology, Division of Cardiology, Department of Medicine, Cardiovascular Research Laboratories, David Geffen School of Medicine at University of California Los Angeles (UCLA), California, 90095
通讯作者:
通讯机构:[1]Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, China[2]Division of Molecular Medicine, Department of Anesthesiology, Division of Cardiology, Department of Medicine, Cardiovascular Research Laboratories, David Geffen School of Medicine at University of California Los Angeles (UCLA), California, 90095
推荐引用方式(GB/T 7714):
Cai Hua,Wang Chen.Graphical review: The redox dark side of e-cigarettes; exposure to oxidants and public health concerns[J].REDOX BIOLOGY.2017,13:402-406.doi:10.1016/j.redox.2017.05.013.
APA:
Cai, Hua&Wang, Chen.(2017).Graphical review: The redox dark side of e-cigarettes; exposure to oxidants and public health concerns.REDOX BIOLOGY,13,
MLA:
Cai, Hua,et al."Graphical review: The redox dark side of e-cigarettes; exposure to oxidants and public health concerns".REDOX BIOLOGY 13.(2017):402-406